ID28304A - Komposisi dispersi molekular dengan ketersediaan-bio yang lebih baik - Google Patents

Komposisi dispersi molekular dengan ketersediaan-bio yang lebih baik

Info

Publication number
ID28304A
ID28304A IDW20001216A ID20001216A ID28304A ID 28304 A ID28304 A ID 28304A ID W20001216 A IDW20001216 A ID W20001216A ID 20001216 A ID20001216 A ID 20001216A ID 28304 A ID28304 A ID 28304A
Authority
ID
Indonesia
Prior art keywords
complexion
better
molecular dispersion
bio availability
bio
Prior art date
Application number
IDW20001216A
Other languages
English (en)
Indonesian (id)
Inventor
Surendra A Sangekar
Ping I Lee
Amin A Nomier
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of ID28304A publication Critical patent/ID28304A/id

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2027Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4866Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
IDW20001216A 1997-12-22 1998-12-17 Komposisi dispersi molekular dengan ketersediaan-bio yang lebih baik ID28304A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US99716897A 1997-12-22 1997-12-22

Publications (1)

Publication Number Publication Date
ID28304A true ID28304A (id) 2001-05-10

Family

ID=25543717

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20001216A ID28304A (id) 1997-12-22 1998-12-17 Komposisi dispersi molekular dengan ketersediaan-bio yang lebih baik

Country Status (28)

Country Link
EP (1) EP1039908B1 (zh)
JP (2) JP2001526227A (zh)
KR (1) KR100597331B1 (zh)
CN (1) CN1116039C (zh)
AR (1) AR017436A1 (zh)
AT (1) ATE260105T1 (zh)
AU (1) AU761994C (zh)
BR (1) BR9813728A (zh)
CA (1) CA2315685C (zh)
CO (1) CO4970793A1 (zh)
CZ (1) CZ295956B6 (zh)
DE (1) DE69821984T2 (zh)
DK (1) DK1039908T3 (zh)
ES (1) ES2214757T3 (zh)
HK (1) HK1027040A1 (zh)
HU (1) HU229052B1 (zh)
ID (1) ID28304A (zh)
IL (1) IL136460A0 (zh)
MY (1) MY126580A (zh)
NO (1) NO327383B1 (zh)
NZ (1) NZ504834A (zh)
PE (1) PE20000012A1 (zh)
PL (1) PL192423B1 (zh)
PT (1) PT1039908E (zh)
SK (1) SK285662B6 (zh)
TW (1) TW527196B (zh)
WO (1) WO1999032118A1 (zh)
ZA (1) ZA9811592B (zh)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6524832B1 (en) 1994-02-04 2003-02-25 Arch Development Corporation DNA damaging agents in combination with tyrosine kinase inhibitors
US6632455B2 (en) 1997-12-22 2003-10-14 Schering Corporation Molecular dispersion composition with enhanced bioavailability
US6316462B1 (en) 1999-04-09 2001-11-13 Schering Corporation Methods of inducing cancer cell death and tumor regression
EP1404300B1 (en) 2001-06-22 2009-09-30 Pfizer Products Inc. Pharmaceutical compositions of dispersions of drugs and neutral polymers
EP1492508A4 (en) * 2002-03-04 2009-05-06 Teva Pharma DOSAGE FORMS WITH CONTROLLED RELEASE
SA07280459B1 (ar) 2006-08-25 2011-07-20 بيورديو فارما إل. بي. أشكال جرعة صيدلانية للتناول عن طريق الفم مقاومة للعبث تشتمل على مسكن شبه أفيوني
PT103661B (pt) 2007-02-23 2010-09-07 Hovione Farmaciencia S A Processo de preparação de minociclina base cristalina
WO2008136392A1 (ja) * 2007-04-27 2008-11-13 Ajinomoto Co., Inc. 経口投与用製剤
US8835635B2 (en) * 2012-06-05 2014-09-16 Symed Labs Limited Amorphous form of vilazodone hydrochloride substantially free of crystalline forms

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2546577B2 (de) * 1975-10-17 1981-04-02 Sandoz-Patent-GmbH, 7850 Lörrach Feste Stoffe aus Polyvinylpyrrolidon und Ergotalkaloiden
EP0214092A1 (en) * 1985-08-08 1987-03-11 Ciba-Geigy Ag Enhanced absorption of psychoactive 2-aryl-pyrazolo quinolines as a solid molecular dispersion in polyvinylpyrrolidone
DE69222182T2 (de) * 1991-12-18 1998-02-26 Warner Lambert Co Verfahren für die herstellung einer festen dispersion
JPH0848632A (ja) * 1994-08-08 1996-02-20 Kanebo Ltd エトポシドを含有する固形組成物および固形製剤
TW350844B (en) * 1995-12-22 1999-01-21 Schering Corp Tricyclic amides useful to inhibition of G-protein function and for treatment of proliferative diseases
ES2224256T3 (es) * 1996-06-28 2005-03-01 Schering Corporation Disolucion solida de un agente antifungico con biodisponibilidad mejorada.

Also Published As

Publication number Publication date
EP1039908B1 (en) 2004-02-25
CO4970793A1 (es) 2000-11-07
NO20003235D0 (no) 2000-06-21
EP1039908A1 (en) 2000-10-04
CZ20002304A3 (cs) 2001-04-11
SK8962000A3 (en) 2001-07-10
CZ295956B6 (cs) 2005-12-14
KR20010033397A (ko) 2001-04-25
DK1039908T3 (da) 2004-05-03
KR100597331B1 (ko) 2006-07-10
AU761994C (en) 2004-01-08
ZA9811592B (en) 1999-06-17
SK285662B6 (sk) 2007-05-03
WO1999032118A1 (en) 1999-07-01
AU761994B2 (en) 2003-06-12
NO20003235L (no) 2000-07-27
CA2315685A1 (en) 1999-07-01
JP2010059212A (ja) 2010-03-18
DE69821984T2 (de) 2004-12-30
CA2315685C (en) 2008-02-05
PE20000012A1 (es) 2000-01-18
PL341344A1 (en) 2001-04-09
ES2214757T3 (es) 2004-09-16
HU229052B1 (en) 2013-07-29
ATE260105T1 (de) 2004-03-15
CN1116039C (zh) 2003-07-30
PT1039908E (pt) 2004-06-30
BR9813728A (pt) 2000-10-10
MY126580A (en) 2006-10-31
CN1282245A (zh) 2001-01-31
NZ504834A (en) 2001-12-21
DE69821984D1 (de) 2004-04-01
IL136460A0 (en) 2001-06-14
NO327383B1 (no) 2009-06-22
AU1814399A (en) 1999-07-12
HK1027040A1 (en) 2001-01-05
AR017436A1 (es) 2001-09-05
HUP0100850A2 (hu) 2001-10-28
PL192423B1 (pl) 2006-10-31
TW527196B (en) 2003-04-11
JP2001526227A (ja) 2001-12-18
HUP0100850A3 (en) 2002-12-28

Similar Documents

Publication Publication Date Title
ID16926A (id) Komposisi-komposisi antijamur dengan ketersediaan biologis yang lebih baik
DE59710092D1 (de) Zentrifugalpumpe und Zentrifugalpumpenanordnung
ID27383A (id) Benda-benda penyerap yang memberikan ketepatan yang lebih baik jika basah
PT1035830E (pt) Composicoes cosmeticas com dibenzilideno-sorbitol e silicones com grupos funcionais
ID21085A (id) Perkaitan dan bidang pemisah listrik untuk perlengkapan komunikasi pemakaian pribadi
ATE189381T1 (de) Starkschäumendes haarfrisiershampoo
ID18210A (id) Campuran zat warna dispersi
ID24370A (id) Polimer-polimer monoviniliden dengan tumbukan yang tinggi dan kehalusan yang tinggi
DE69820519D1 (de) Haarkosmetische Zubereitung
DE59804418D1 (de) Kosmetische zubereitungen
ID28304A (id) Komposisi dispersi molekular dengan ketersediaan-bio yang lebih baik
ID22894A (id) Dispersi berair
ID23159A (id) Wafer dan pembuatannya
DE59912915D1 (de) Herstellung von 4,4'-Diketo-carotinoiden
ID16154A (id) Komposisi monomer yang distabilisasi
DE59700410D1 (de) Haarreinigungsmittel mit Festigungseigenschaften
DE59711315D1 (de) Herstellung von Polybenzoxazol- und Polybenzothiazol-Vorstufen
FI961038A0 (fi) Parannuksia matkaviestinverkoissa tai niihin liittyen
DE69733607D1 (de) Herstellung von cycloalkyldiarylphosphinen
FI956005A0 (fi) Tastaturstruktur som minskar elektromagnetisk stoerning
DE69706301D1 (de) Haarfixierungsmittel formuliert mit silikon-copolyolen
DE69737529D1 (de) Herstellung von 1-butyl-4-piperidinylmethylamin
FI973286A0 (fi) System och anordning foer uppsamling av spillning pao en paelsdjursfarm
FI974235A0 (fi) Ny bestaemningsmetod
NO984307D0 (no) Anvendelsen av spesielle tilberedninger som avskummere